The logo painted outside the World Health Organization (WHO) building in Geneva, Switzerland, on April 6, 2021.file photo / Reuters
NEW DELHI: On Wednesday, the World Health Organization (WHO) said four types of cough syrup and cold syrup manufactured by India’s Maiden Pharmaceuticals Co. were linked to severe kidney damage and the death of 66 children in Gambia. He said it may be related.
New Delhi-based Maiden Pharmaceuticals declined to comment.
The WHO issued a medical product warning on the four syrups and said it was conducting further investigations with the company and Indian regulators.
The Gambian government said last month that it was also investigating deaths after a spike in acute kidney injury in children under the age of five was detected in late July.
WHO Director-General Tedros Adhanom Ghebreyesus said at a press conference on Wednesday that “contaminated products have so far only been detected in The Gambia, but may have been distributed to other countries.” rice field.
He added that the WHO recommends that all countries detect and remove these products from circulation to prevent further harm to patients.